中国生物科技服务完成发行本金总额为3500万美元的可换股债券

Group 1 - The company has completed the issuance of convertible bonds totaling $35 million, with all conditions of the subscription agreement met [1] - Prior to the issuance of the new convertible bonds, there remains an outstanding principal amount of $6 million from the 2024 convertible bonds, which can be converted into approximately 39.25 million shares at a conversion price of HKD 1.20 per share [1]